tetano
Editor, Senior Moderator
Trends Pharmacol Sci. 2014 Jan 14. pii: S0165-6147(13)00226-5. doi: 10.1016/j.tips.2013.11.006. [Epub ahead of print]
Current progress in antiviral strategies.
Lou Z1, Sun Y2, Rao Z3.
Author information
Abstract
The prevalence of chronic viral infectious diseases, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), and influenza virus; the emergence and re-emergence of new viral infections, such as picornaviruses and coronaviruses; and, particularly, resistance to currently used antiviral drugs have led to increased demand for new antiviral strategies and reagents. Increased understanding of the molecular mechanisms of viral infection has provided great potential for the discovery of new antiviral agents that target viral proteins or host factors. Virus-targeting antivirals can function directly or indirectly to inhibit the biological functions of viral proteins, mostly enzymatic activities, or to block viral replication machinery. Host-targeting antivirals target the host proteins that are involved in the viral life cycle, regulating the function of the immune system or other cellular processes in host cells. Here we review key targets and considerations for the development of both antiviral strategies.
Copyright ? 2013 Elsevier Ltd. All rights reserved.
KEYWORDS:
direct virus-targeting antiviral, host-targeting antiviral, indirect virus-targeting antiviral
PMID:
24439476
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/24439476
Current progress in antiviral strategies.
Lou Z1, Sun Y2, Rao Z3.
Author information
Abstract
The prevalence of chronic viral infectious diseases, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), and influenza virus; the emergence and re-emergence of new viral infections, such as picornaviruses and coronaviruses; and, particularly, resistance to currently used antiviral drugs have led to increased demand for new antiviral strategies and reagents. Increased understanding of the molecular mechanisms of viral infection has provided great potential for the discovery of new antiviral agents that target viral proteins or host factors. Virus-targeting antivirals can function directly or indirectly to inhibit the biological functions of viral proteins, mostly enzymatic activities, or to block viral replication machinery. Host-targeting antivirals target the host proteins that are involved in the viral life cycle, regulating the function of the immune system or other cellular processes in host cells. Here we review key targets and considerations for the development of both antiviral strategies.
Copyright ? 2013 Elsevier Ltd. All rights reserved.
KEYWORDS:
direct virus-targeting antiviral, host-targeting antiviral, indirect virus-targeting antiviral
PMID:
24439476
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/24439476